LodeHQ
AI news for people who shipFree, by email

Founders · Wednesday, 15 July 2026 · Issue 43 · 9 stories

OpenAI alum's $2B drug AI, DeepSeek's $71B raise

Funding & VC

Former OpenAI researcher launches $2B AI drug‑discovery startup

Miles Wang, ex‑OpenAI researcher, is founding SynthiAI, an AI‑driven drug discovery platform that has already secured a $2 billion valuation in talks with top VCs. The startup aims to cut lead‑time for new therapeutics by applying large language models to molecular design, signaling a major push of generative AI into pharma.

syntai.com ↗4 min read at source

Leadership & Lessons

AI offloading threatens the problem‑solving edge of knowledge workers

Knowledge workers are letting LLMs do the heavy lifting of research, reasoning, and decision‑making. The ease of AI offloading risks eroding the deep problem‑solving muscles that fuel innovation and sound judgment, especially as models move from search‑assistants to autonomous thinkers. Reclaiming autonomous thinking is now a leadership priority.

artfish.ai ↗8 min read at source

You’re caught up.

That was all 9 stories in the 15 July issue.